95 related articles for article (PubMed ID: 2711161)
1. [Treatment of anemia in hemodialysis patients using recombinant human erythropoietin: advantages and disadvantages].
Zehnder C; Blumberg A
Schweiz Med Wochenschr; 1989 Mar; 119(9):269-75. PubMed ID: 2711161
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J
Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy].
Eiselt J; Veselá E; Racek J
Vnitr Lek; 1994 Jul; 40(7):437-9. PubMed ID: 8073661
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
Stutz B; Rhyner K; Vögtli J; Binswanger U
Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
Lebel M; Kingma I; Grose JH; Langlois S
Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237
[TBL] [Abstract][Full Text] [Related]
8. [Use of recombinant erythropoietin on secondary anemia in patients in the terminal phase of renal insufficiency on hemodialysis].
Gasparović V; Puretić Z; Vrhovac B; Gjurasin M; Puljević D
Acta Med Iugosl; 1990; 44(2):129-35. PubMed ID: 2353593
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of anemia in children undergoing chronic hemodialysis with recombinant human erythropoietin].
Rendo P; Biscigniano L; Turconi A; Sánchez Avalos JC; Greco J
Medicina (B Aires); 1994; 54(5 Pt 1):392-8. PubMed ID: 7658972
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.
Churchill DN; Muirhead N; Goldstein M; Posen G; Fay W; Beecroft ML; Gorman J; Taylor DW
Clin Nephrol; 1995 Mar; 43(3):184-8. PubMed ID: 7774076
[TBL] [Abstract][Full Text] [Related]
13. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
Sikole A; Spasovski G; Zafirov D; Polenakovic M
Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
[TBL] [Abstract][Full Text] [Related]
14. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
Barclay PG; Fischer ER; Harris DC
Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
[TBL] [Abstract][Full Text] [Related]
15. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
16. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
[TBL] [Abstract][Full Text] [Related]
17. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
Di Iorio B; Guastaferro P; Gironda A; Marano V; Morrongiello L; Cillo N; Zito B; Nigro F; Frieri A; Rubino R; Bellizzi V
G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group.
Laupacis A
Transplant Proc; 1991 Apr; 23(2):1825-6. PubMed ID: 2053167
[TBL] [Abstract][Full Text] [Related]
19. Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients?
Goodnough LT; Strasburg D; Riddell J; Verbrugge D; Wish J
Clin Nephrol; 1994 May; 41(5):303-7. PubMed ID: 8050211
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]